{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T20:20:43Z","timestamp":1793996443850,"version":"4.8.0"},"reference-count":53,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T00:00:00Z","timestamp":1744070400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>The Glasgow Prognostic Score (GPS) is a well-established prognostic indicator that effectively reflects the inflammatory, nutritional, and immune status of cancer patients. GPS has been shown to be associated with survival outcomes in many different cancers. However, its prognostic significance in biliary tract cancer (BTC) remains unclear. This meta-analysis aims to explore the prognostic value of GPS in BTC patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>A systematic search was conducted in PubMed, Embase, and Web of Science to identify relevant studies. Survival data including overall survival (OS), disease-free survival (DFS) and recurrence-free survival (RFS) were the main observation indicators. Hazard ratios (HRs) with 95% confidence intervals (CIs) were extracted and pooled for meta-analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>A total of 16 articles incorporating 1919 patients were included in the study. High GPS was associated with poor OS (HR:2.00, 95% CI:1.62-2.48) and DFS\/RFS (HR:2.50, 95% CI:1.71-3.65). Subgroup analysis further confirmed the prognosis value of GPS in BTC patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>GPS could serves as a valuable prognostic marker in BTC patients and may aid in risk stratification and treatment decision-making.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fimmu.2025.1560944","type":"journal-article","created":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T03:12:45Z","timestamp":1744081965000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Preoperative glasgow prognostic score was an effective prognostic indicator in patients with biliary tract cancer"],"prefix":"10.3389","volume":"16","author":[{"given":"Rongqiang","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wangbin","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ximing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jia","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weixing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,4,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660","article-title":"Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"71","author":"Sung","year":"2021","journal-title":"CA Cancer J Clin"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1200\/edbk_160831","article-title":"Biliary tract cancer: epidemiology, radiotherapy, and molecular profiling","volume":"35","author":"Bridgewater","year":"2016","journal-title":"Am Soc Clin Oncol Educ book. Am Soc Clin Oncol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.esmoop.2022.100503","article-title":"Advances in the systemic treatment of therapeutic approaches in biliary tract cancer","volume":"7","author":"Mirallas","year":"2022","journal-title":"ESMO Open"},{"key":"B4","doi-asserted-by":"publisher","first-page":"61","DOI":"10.21037\/cco.2016.10.09","article-title":"Biliary tract cancers: epidemiology, molecular pathogenesis and genetic risk associations","volume":"5","author":"Marcano-Bonilla","year":"2016","journal-title":"Chin Clin Oncol"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/s0140-6736(21)00153-7","article-title":"Biliary tract cancer","volume":"397","author":"Valle","year":"2021","journal-title":"Lancet (London England)"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2012.06.006","article-title":"Biliary tract carcinomas: from chemotherapy to targeted therapy","volume":"85","author":"Marino","year":"2013","journal-title":"Crit Rev Oncol Hematol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ctarc.2021.100354","article-title":"Neoadjuvant therapy for cholangiocarcinoma: A comprehensive literature review","volume":"27","author":"Rizzo","year":"2021","journal-title":"Cancer Treat Res Commun"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1007\/s10238-023-01159-1","article-title":"The impact of ECOG performance status on efficacy of immunotherapy and immune-based combinations in cancer patients: the MOUSEION-06 study","volume":"23","author":"Mollica","year":"2023","journal-title":"Clin Exp Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1080\/17474124.2021.1890031","article-title":"Pitfalls, challenges, and updates in adjuvant systemic treatment for resected biliary tract cancer","volume":"15","author":"Rizzo","year":"2021","journal-title":"Expert Rev Gastroenterol Hepatol"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.21873\/anticanres.14282","article-title":"Second-line treatment in advanced biliary tract cancer: today and tomorrow","volume":"40","author":"Rizzo","year":"2020","journal-title":"Anticancer Res"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1177\/1073274820948047","article-title":"Immunotherapy in biliary tract cancer: worthy of a second look","volume":"27","author":"Ricci","year":"2020","journal-title":"Cancer Control"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1136\/esmoopen-2020-001042","article-title":"The DNA damage repair (DDR) pathway in biliary tract cancer (BTC): a new Pandora\u2019s box","volume":"5","author":"Ricci","year":"2020","journal-title":"ESMO Open"},{"key":"B13","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1002\/jpen.2259","article-title":"Nutrition in cancer therapy: Overview for the cancer patient","volume":"45","author":"Chapek","year":"2021","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s12029-021-00584-3","article-title":"Preoperative utility of the glasgow prognostic score on outcomes of patients with locally advanced gastric cancer","volume":"53","author":"Shimoda","year":"2022","journal-title":"J Gastrointest Cancer"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1007\/s00432-015-2113-0","article-title":"Comparison of the Glasgow Prognostic Score (GPS) and the modified Glasgow Prognostic Score (mGPS) in evaluating the prognosis of patients with operable and inoperable non-small cell lung cancer","volume":"142","author":"Fan","year":"2016","journal-title":"J Cancer Res Clin Oncol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s00404-020-05581-8","article-title":"A high Glasgow prognostic score (GPS) or modified Glasgow prognostic score (mGPS) predicts poor prognosis in gynecologic cancers: a systematic review and meta-analysis","volume":"301","author":"Nie","year":"2020","journal-title":"Arch gynecol obstet"},{"key":"B17","doi-asserted-by":"publisher","first-page":"531","DOI":"10.21037\/atm.2019.09.160","article-title":"Pre-treatment Glasgow prognostic score and modified Glasgow prognostic score may be potential prognostic biomarkers in urological cancers: a systematic review and meta-analysis","volume":"7","author":"Qi","year":"2019","journal-title":"Ann Trans Med"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.gassur.2024.01.023","article-title":"Prognostic value of the modified Glasgow prognostic score in biliary tract cancer patients: a systematic review and meta-analysis","volume":"28","author":"Zhou","year":"2024","journal-title":"J Gastrointest Surg"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1016\/j.jss.2019.01.033","article-title":"The comparison of inflammation-based prognostic scores in patients with extrahepatic bile duct cancer after pancreaticoduodenectomy","volume":"238","author":"Fujiwara","year":"2019","journal-title":"J Surg Res"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejso.2019.12.008","article-title":"Prognostic value of preoperative inflammatory markers in resectable biliary tract cancer - Validation and comparison of the Glasgow Prognostic Score and Modified Glasgow Prognostic Score in a Western cohort","volume":"46","author":"Jansson","year":"2020","journal-title":"Eur J Surg Oncol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1159\/000499050","article-title":"Association of preoperative platelet-to-lymphocyte ratio with poor outcome in patients with distal cholangiocarcinoma","volume":"96","author":"Hoshimoto","year":"2019","journal-title":"Oncology"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1007\/s11605-018-3892-9","article-title":"Clinical value of inflammation-based prognostic scores to predict the resectability of hyperbilirubinemia patients with potentially resectable hilar cholangiocarcinoma","volume":"23","author":"Hu","year":"2019","journal-title":"J Gastrointest Surg"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1007\/s10654-010-9491-z","article-title":"Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses","volume":"25","author":"Stang","year":"2010","journal-title":"Eur J Epidemiol"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1186\/1745-6215-8-16","article-title":"Practical methods for incorporating summary time-to-event data into meta-analysis","volume":"8","author":"Tierney","year":"2007","journal-title":"Trials"},{"key":"B25","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1159\/000521969","article-title":"Prognostic impact of inflammation-based scores for extrahepatic cholangiocarcinoma","volume":"39","author":"Asakura","year":"2022","journal-title":"Digest surge"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.5582\/bst.2020.03326","article-title":"The C-reactive protein to albumin ratio is an excellent prognostic predictor for gallbladder cancer","volume":"14","author":"Bao","year":"2021","journal-title":"Biosci trends"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.3390\/cancers13143594","article-title":"Role of inflammatory and immune-nutritional prognostic markers in patients undergoing surgical resection for biliary tract cancers","volume":"13","author":"Conci","year":"2021","journal-title":"Cancers (Basel)"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-013-0787-1","article-title":"The Glasgow Prognostic Score accurately predicts survival in patients with biliary tract cancer not indicated for surgical resection","volume":"31","author":"Iwaku","year":"2014","journal-title":"Med Oncol (Northwood London England)"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.2147\/cmar.s198959","article-title":"Comparative performance of inflammation-based prognostic scores in patients operated for intrahepatic cholangiocarcinoma","volume":"11","author":"Lin","year":"2019","journal-title":"Cancer Manage Res"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.1002\/bjs5.50348","article-title":"C-reactive protein\u2009:\u2009albumin ratio in patients with resectable intrahepatic cholangiocarcinoma","volume":"4","author":"Matsumoto","year":"2020","journal-title":"BJS Open"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-014-0287-y","article-title":"Glasgow Prognostic Score predicts poor prognosis among advanced biliary tract cancer patients with good performance status","volume":"31","author":"Moriwaki","year":"2014","journal-title":"Med Oncol (Northwood London England)"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1007\/s00534-012-0550-6","article-title":"Inflammation-based prognostic score is a useful predictor of postoperative outcome in patients with extrahepatic cholangiocarcinoma","volume":"20","author":"Oshiro","year":"2013","journal-title":"J Hepatobil Pancreat Sci"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.3892\/mco.2017.1166","article-title":"Glasgow Prognostic Score predicts prognosis of intrahepatic cholangiocarcinoma","volume":"6","author":"Pan","year":"2017","journal-title":"Mol Clin Oncol"},{"key":"B34","article-title":"Glasgow prognostic score predicts therapeutic outcome after pancreaticoduodenectomy for carcinoma of the ampulla of vater","volume":"33","author":"Shiba","year":"2013","journal-title":"Anticancer Res"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1007\/s00268-020-05797-4","article-title":"Prognostic utility of the glasgow prognostic score for the long-term outcomes after liver resection for intrahepatic cholangiocarcinoma: A multi-institutional study","volume":"45","author":"Sui","year":"2021","journal-title":"World J surge"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.2147\/jir.s385921","article-title":"Inflammation-based scores predict responses to PD-1 inhibitor treatment in intrahepatic cholangiocarcinoma","volume":"15","author":"Yang","year":"2022","journal-title":"J Inflamm Res"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1080\/01635581.2022.2104876","article-title":"Prognostic and clinicopathological significance of C-reactive protein to albumin ratio in patients with bile duct cancer: A meta-analysis","volume":"76","author":"Dai","year":"2024","journal-title":"Nutr Cancer"},{"key":"B38","doi-asserted-by":"publisher","first-page":"6988489","DOI":"10.1155\/2022\/6988489","article-title":"Prognostic and clinical value of the systemic immune-inflammation index in biliary tract cancer: A meta-analysis","volume":"2022","author":"Peng","year":"2022","journal-title":"J Immunol Res"},{"key":"B39","doi-asserted-by":"publisher","first-page":"2137","DOI":"10.3390\/cancers14092137","article-title":"Changing landscape of systemic therapy in biliary tract cancer","volume":"14","author":"Woods","year":"2022","journal-title":"Cancers (Basel)"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bjc.6601789","article-title":"Comparison of an inflammation-based prognostic score (GPS) with performance status (ECOG) in patients receiving platinum-based chemotherapy for inoperable non-small-cell lung cancer","volume":"90","author":"Forrest","year":"2004","journal-title":"Br J cancer"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1002\/hep.1840120517","article-title":"Acute-phase response of human hepatocytes: regulation of acute-phase protein synthesis by interleukin-6","volume":"12","author":"Castell","year":"1990","journal-title":"Hepatol (Baltimore Md.)"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.can-06-2130","article-title":"Interleukin-6 contributes to growth in cholangiocarcinoma cells by aberrant promoter methylation and gene expression","volume":"66","author":"Wehbe","year":"2006","journal-title":"Cancer Res"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2019-000234","article-title":"C reactive protein impairs adaptive immunity in immune cells of patients with melanoma","volume":"8","author":"Yoshida","year":"2020","journal-title":"J Immunother Cancer"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1093\/abbs\/gmy004","article-title":"C-reactive protein is associated with the development of tongue squamous cell carcinoma","volume":"50","author":"Du","year":"2018","journal-title":"Acta Biochim Biophys Sin (Shanghai)"},{"key":"B45","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1186\/s12916-022-02506-x","article-title":"C-reactive protein and cancer risk: a pan-cancer study of prospective cohort and Mendelian randomization analysis","volume":"20","author":"Zhu","year":"2022","journal-title":"BMC Med"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.suc.2011.04.004","article-title":"The relationships of nutrients, routes of delivery, and immunocompetence","volume":"91","author":"Jayarajan","year":"2011","journal-title":"Surg Clinics North America"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1207\/S15327914nc392_8","article-title":"Albumin concentrations are primarily determined by the body cell mass and the systemic inflammatory response in cancer patients with weight loss","volume":"39","author":"McMillan","year":"2001","journal-title":"Nutr Cancer"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1007\/s00535-013-0787-0","article-title":"Cancer cachexia\u2013pathophysiology and management","volume":"48","author":"Suzuki","year":"2013","journal-title":"J Gastroenterol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3390\/ijms15035163","article-title":"Albumin suppresses human hepatocellular carcinoma proliferation and the cell cycle","volume":"15","author":"Nojiri","year":"2014","journal-title":"Int J Mol Sci"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1186\/2110-5820-3-4","article-title":"Specific antioxidant properties of human serum albumin","volume":"3","author":"Taverna","year":"2013","journal-title":"Ann Intensive Care"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-006-9093-x","article-title":"Serum albumin as a significant prognostic factor for patients with gastric carcinoma","volume":"14","author":"O\u00f1ate-Oca\u00f1a","year":"2007","journal-title":"Ann Surg Oncol"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1002\/lary.25877","article-title":"Prognostic value of albumin in patients with head and neck cancer","volume":"126","author":"Danan","year":"2016","journal-title":"Laryngos"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.6061\/clinics\/2013(05)17","article-title":"Prognostic impact of serum albumin levels on the recurrence of stage I non-small cell lung cancer","volume":"68","author":"Jin","year":"2013","journal-title":"Clinics (Sao Paulo Brazil)"}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1560944\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T03:12:56Z","timestamp":1744081976000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2025.1560944\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,8]]},"references-count":53,"alternative-id":["10.3389\/fimmu.2025.1560944"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2025.1560944","relation":{},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,8]]},"article-number":"1560944"}}